OpenBilldrug price receipt

NADAC week of 2026-10-14

METOPROLOL SUCC ER 50 MG TAB

For 30 tablets

Pharmacies pay

$1.55 filed

30 × $0.05152 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$5.48 filed

30 × $0.18251 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

3.5× estimated

Medicare paid 3.5× what pharmacies pay.

Part D averages every strength and form sold under “Metoprolol Succinate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$6.78 estimated

$1.55 + $0.23 (15%) + $5.00 fee per fill = $6.78

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

METOPROLOL SUCC ER 50 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “metoprolol succinate” and “metoprolol succinate er tablets”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, film coated, extended release” and “tablet, extended release” and its route as oral.

FDA lists 17 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Cranbury Pharmaceuticals, LLC and Camber Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is beta-Adrenergic Blocker.

The NADAC file of 2026-10-14 prices it under 46 NDCs (National Drug Codes); the FDA directory lists 43 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.55 for 30 tablets (30 × $0.05152 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 17 labelers

LabelerNDCsPharmacies pay per unit
BluePoint Laboratories5$0.05152 per EA filed
Dr. Reddy's Laboratories Limited4$0.05152 per EA filed
Oryza pharmaceuticals Inc.4$0.05152 per EA filed
Camber Pharmaceuticals, Inc.3$0.05152 per EA filed
Cranbury Pharmaceuticals, LLC3$0.05152 per EA filed
Epic Pharma, LLC3$0.05152 per EA filed
Granules Pharmaceuticals Inc.3$0.05152 per EA filed
Northstar Rx LLC3$0.05152 per EA filed
Actavis Pharma, Inc.2$0.05152 per EA filed
American Health Packaging2$0.05152 per EA filed
Ascend Laboratories, LLC2$0.05152 per EA filed
Cipla USA Inc.2$0.05152 per EA filed
Ingenus Pharmaceuticals, LLC2$0.05152 per EA filed
Zydus Pharmaceuticals (USA) Inc.2$0.05152 per EA filed
AvPAK1$0.05152 per EA filed
Major Pharmaceuticals1$0.05152 per EA filed
Quallent Pharmaceuticals Health LLC1$0.05152 per EA filed
Not listed as a package in the FDA directory3$0.05152 per EA filed
All 46 NDCs, with labeler and price
  • 00904-6323-61 · Major Pharmaceuticals · $0.05152 per EA · eff. 2026-09-23 filed
  • 27808-0303-01 · Cranbury Pharmaceuticals, LLC · $0.05152 per EA · eff. 2026-09-23 filed
  • 27808-0303-02 · Cranbury Pharmaceuticals, LLC · $0.05152 per EA · eff. 2026-09-23 filed
  • 27808-0303-03 · Cranbury Pharmaceuticals, LLC · $0.05152 per EA · eff. 2026-09-23 filed
  • 31722-0590-01 · Camber Pharmaceuticals, Inc. · $0.05152 per EA · eff. 2026-09-23 filed
  • 31722-0590-05 · Camber Pharmaceuticals, Inc. · $0.05152 per EA · eff. 2026-09-23 filed
  • 31722-0590-10 · Camber Pharmaceuticals, Inc. · $0.05152 per EA · eff. 2026-09-23 filed
  • 42806-0725-01 · Epic Pharma, LLC · $0.05152 per EA · eff. 2026-09-23 filed
  • 42806-0725-05 · Epic Pharma, LLC · $0.05152 per EA · eff. 2026-09-23 filed
  • 42806-0725-10 · Epic Pharma, LLC · $0.05152 per EA · eff. 2026-09-23 filed
  • 45963-0676-11 · Actavis Pharma, Inc. · $0.05152 per EA · eff. 2026-09-23 filed
  • 45963-0676-96 · Actavis Pharma, Inc. · $0.05152 per EA · eff. 2026-09-23 filed
  • 50268-0541-11 · not listed as a package in the FDA directory · $0.05152 per EA · eff. 2026-09-23 filed
  • 50268-0541-15 · AvPAK · $0.05152 per EA · eff. 2026-09-23 filed
  • 50742-0616-01 · Ingenus Pharmaceuticals, LLC · $0.05152 per EA · eff. 2026-09-23 filed
  • 50742-0616-10 · Ingenus Pharmaceuticals, LLC · $0.05152 per EA · eff. 2026-09-23 filed
  • 55111-0467-01 · Dr. Reddy's Laboratories Limited · $0.05152 per EA · eff. 2026-09-23 filed
  • 55111-0467-05 · Dr. Reddy's Laboratories Limited · $0.05152 per EA · eff. 2026-09-23 filed
  • 60687-0402-01 · American Health Packaging · $0.05152 per EA · eff. 2026-09-23 filed
  • 60687-0402-11 · not listed as a package in the FDA directory · $0.05152 per EA · eff. 2026-09-23 filed
  • 60687-0402-65 · American Health Packaging · $0.05152 per EA · eff. 2026-09-23 filed
  • 67877-0591-01 · Ascend Laboratories, LLC · $0.05152 per EA · eff. 2026-09-23 filed
  • 67877-0591-05 · Ascend Laboratories, LLC · $0.05152 per EA · eff. 2026-09-23 filed
  • 68001-0469-00 · BluePoint Laboratories · $0.05152 per EA · eff. 2026-09-23 filed
  • 68001-0501-00 · BluePoint Laboratories · $0.05152 per EA · eff. 2026-09-23 filed
  • 68001-0501-03 · BluePoint Laboratories · $0.05152 per EA · eff. 2026-09-23 filed
  • 68001-0685-00 · BluePoint Laboratories · $0.05152 per EA · eff. 2026-09-23 filed
  • 68001-0685-03 · BluePoint Laboratories · $0.05152 per EA · eff. 2026-09-23 filed
  • 68382-0565-01 · Zydus Pharmaceuticals (USA) Inc. · $0.05152 per EA · eff. 2026-09-23 filed
  • 68382-0565-10 · Zydus Pharmaceuticals (USA) Inc. · $0.05152 per EA · eff. 2026-09-23 filed
  • 68645-0478-54 · not listed as a package in the FDA directory · $0.05152 per EA · eff. 2026-09-23 filed
  • 69097-0407-07 · Cipla USA Inc. · $0.05152 per EA · eff. 2026-09-23 filed
  • 69097-0407-15 · Cipla USA Inc. · $0.05152 per EA · eff. 2026-09-23 filed
  • 70010-0781-01 · Granules Pharmaceuticals Inc. · $0.05152 per EA · eff. 2026-09-23 filed
  • 70010-0781-05 · Granules Pharmaceuticals Inc. · $0.05152 per EA · eff. 2026-09-23 filed
  • 70010-0781-10 · Granules Pharmaceuticals Inc. · $0.05152 per EA · eff. 2026-09-23 filed
  • 72516-0026-10 · Oryza pharmaceuticals Inc. · $0.05152 per EA · eff. 2026-09-23 filed
  • 72516-0031-01 · Oryza Pharmaceuticals, Inc · $0.05152 per EA · eff. 2026-09-23 filed
  • 72516-0031-10 · Oryza Pharmaceuticals, Inc · $0.05152 per EA · eff. 2026-09-23 filed
  • 72516-0031-50 · Oryza Pharmaceuticals, Inc · $0.05152 per EA · eff. 2026-09-23 filed
  • 72603-0143-01 · Northstar Rx LLC · $0.05152 per EA · eff. 2026-09-23 filed
  • 72603-0143-02 · Northstar Rx LLC · $0.05152 per EA · eff. 2026-09-23 filed
  • 72603-0143-03 · Northstar Rx LLC · $0.05152 per EA · eff. 2026-09-23 filed
  • 75907-0347-01 · Dr. Reddy's Laboratories Inc · $0.05152 per EA · eff. 2026-09-23 filed
  • 75907-0347-10 · Dr. Reddy's Laboratories Inc · $0.05152 per EA · eff. 2026-09-23 filed
  • 82009-0114-05 · Quallent Pharmaceuticals Health LLC · $0.05152 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

10 other products in the NADAC file share an FDA nonproprietary name with METOPROLOL SUCC ER 50 MG TAB.

ProductPharmacies pay per unitMedicare per unit
KAPSPARGO SPRINKLE 25 MG CAP
brand · capsule, extended release
$1.88783 per EA filed
eff. 2026-09-23
We don’t know yet
KAPSPARGO SPRINKLE 50 MG CAP
brand · capsule, extended release
$1.88748 per EA filed
eff. 2026-09-23
We don’t know yet
KAPSPARGO SPRINKLE 100 MG CAP
brand · capsule, extended release
$2.29279 per EA filed
eff. 2026-09-23
We don’t know yet
METOPROLOL SUCC ER 25 MG TAB
generic · tablet, film coated, extended release / tablet, extended release
$0.04762 per EA filed
eff. 2026-09-23
$0.18251 per EA filed
Part D 2024 average
METOPROLOL SUCC ER 50 MG TAB this page
generic · tablet, film coated, extended release / tablet, extended release
$0.05152 per EA filed
eff. 2026-09-23
$0.18251 per EA filed
Part D 2024 average
METOPROLOL SUCC ER 100 MG TAB
generic · tablet, film coated, extended release / tablet, extended release
$0.08496 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.18251 per EA filed
Part D 2024 average
METOPROLOL SUCC ER 200 MG TAB
generic · tablet, extended release / tablet, film coated, extended release
$0.188 per EA filed
eff. 2026-09-23
$0.18251 per EA filed
Part D 2024 average
TOPROL XL 25 MG TABLET
brand · tablet, extended release
$1.38564 per EA filed
eff. 2026-07-01
$1.45252 per EA filed
Part D 2024 average
TOPROL XL 50 MG TABLET
brand · tablet, extended release
$1.38525 per EA filed
eff. 2026-07-01
$1.45252 per EA filed
Part D 2024 average
TOPROL XL 100 MG TABLET
brand · tablet, extended release
$2.07883 per EA filed
eff. 2026-07-01
$1.45252 per EA filed
Part D 2024 average
TOPROL XL 200 MG TABLET
brand · tablet, extended release
$3.3208 per EA filed
eff. 2026-07-01
$1.45252 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01, 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 46 NDCs’ NADAC prices is $0.05152 per EA filed.

Of the 76 other products in FDA’s beta-Adrenergic Blocker class priced per EA, 63 have a higher middle NADAC price and 13 a lower one. The one in the middle is NADOLOL 40 MG TABLET, at $0.26544 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $5.48 for 30 tablets, at an average of $0.18251 per EA in 2024 (2024-01-01 to 2024-12-31) for “Metoprolol Succinate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 32,213,092 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

45 of the product’s 46 NDCs have this Medicare figure; the other 1 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for METOPROLOL SUCC ER 50 MG TAB labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Metoprolol Succinate / Metoprolol Succinate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.